Privately-held German biotech Tacalyx has appointed Jean Engela as chief executive (CEO).

US biotech Citius Oncology (Nasdaq: CTOR) has launched Lymphir (denileukin diftitox-cxdl), its first commercial product, ...

US pharma major Eli Lilly (NYSE: LLY) has lowered the price of Zepbound (tirzepatide) single-dose vials on its Lilly Direct ...

Regulators have squeezed a lot into the late-November cycle. In Europe, the European Medicines Agency's (EMA) Committee for ...

The Association for Accessible Medicines (AAM) has welcomed House passage of Q1/Q2 legislation embedded in the Give Kids a ...

A regenerative medicine company developing stem cell-derived engineered tissues intended to restore organ function, with an ...

San Diego-based Protego Biopharma, a biotech developing small molecule therapeutics that reprogram protein folding to address ...

Canadian biotech Morphocell Technologies has completed its series A at $50 million after a $10 million extension led by ...

Shares of San Diego, USA-based Belite Bio shot up 16.4% to $160.00 in pre-market activity today, after it announced top-line ...

Shares of US clinical-stage biotech Q32 Bio were up a massive 150% at $5.48 by mid-morning after it revealed that it has sold ...

UK-based NRG Therapeutics has announced the expansion of its team with the appointment of Paul Thompson as chief development ...

A pair of biosimilar companies have launched their copies of a big-selling monoclonal antibody used to treat various bone ...